Level Four Advisory Services’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $862K | Buy |
12,003
+2,373
| +25% | +$183K | 0.03% | 451 |
|
|
2025
Q4 | $764K | Buy |
9,630
+1,102
| +13% | +$86.9K | 0.03% | 465 |
|
|
2025
Q3 | $643K | Sell |
8,528
-642
| -7% | -$44K | 0.02% | 496 |
|
|
2025
Q2 | $633K | Sell |
9,170
-137,431
| -94% | -$9.01M | 0.02% | 469 |
|
|
2025
Q1 | $9.93M | Buy |
146,601
+49,307
| +51% | +$2.95M | 0.41% | 47 |
|
|
2024
Q4 | $4.37M | Sell |
97,294
-35,230
| -27% | -$1.98M | 0.18% | 153 |
|
|
2024
Q3 | $7.48M | Buy |
132,524
+34,446
| +35% | +$2.01M | 0.32% | 71 |
|
|
2024
Q2 | $5.79M | Buy |
98,078
+9,199
| +10% | +$575K | 0.26% | 102 |
|
|
2024
Q1 | $7.02M | Buy |
88,879
+821
| +0.9% | +$62.7K | 0.39% | 52 |
|
|
2023
Q4 | $6.95M | Sell |
88,058
-8,882
| -9% | -$632K | 0.39% | 51 |
|
|
2023
Q3 | $6.77M | Buy |
96,940
+3,957
| +4% | +$280K | 0.44% | 44 |
|
|
2023
Q2 | $6.43M | Buy |
92,983
+14,100
| +18% | +$1M | 0.39% | 51 |
|
|
2023
Q1 | $5.86M | Buy |
78,883
+13,580
| +21% | +$1.14M | 0.38% | 52 |
|
|
2022
Q4 | $6.09M | Buy |
65,303
+8,304
| +15% | +$801K | 0.45% | 51 |
|
|
2022
Q3 | $5.44M | Buy |
56,999
+792
| +1% | +$78.4K | 0.53% | 41 |
|
|
2022
Q2 | $5.21M | Buy |
56,207
+4,266
| +8% | +$416K | 0.49% | 43 |
|
|
2022
Q1 | $5.26M | Sell |
51,941
-1,654
| -3% | -$174K | 0.41% | 57 |
|
|
2021
Q4 | $5.53M | Buy |
53,595
+16,327
| +44% | +$1.51M | 0.42% | 53 |
|
|
2021
Q3 | $3.16M | Sell |
37,268
-4,010
| -10% | -$336K | 0.33% | 90 |
|
|
2021
Q2 | $3.44M | Buy |
41,278
+29,913
| +263% | +$2.45M | 0.24% | 111 |
|
|
2021
Q1 | $855K | Buy |
11,365
+631
| +6% | +$46K | 0.07% | 289 |
|
|
2020
Q4 | $733K | Buy |
10,734
+2,775
| +35% | +$180K | 0.06% | 293 |
|
|
2020
Q3 | $465K | Sell |
7,959
-2,220
| -22% | -$138K | 0.04% | 359 |
|
|
2020
Q2 | $660K | Buy |
10,179
+34
| +0.3% | +$2.14K | 0.05% | 319 |
|
|
2020
Q1 | $607K | Sell |
10,145
-1,129
| -10% | -$75.4K | 0.07% | 284 |
|
|
2019
Q4 | $913K | Buy |
11,274
+1,599
| +17% | +$112K | 0.04% | 292 |
|
|
2019
Q3 | $610K | Sell |
9,675
-197
| -2% | -$11.7K | 0.06% | 292 |
|
|
2019
Q2 | $538K | Buy |
9,872
+3,556
| +56% | +$191K | 0.05% | 307 |
|
|
2019
Q1 | $341K | Sell |
6,316
-149
| -2% | -$9.2K | 0.04% | 382 |
|
|
2018
Q4 | $424K | Buy |
6,465
+1,590
| +33% | +$119K | 0.05% | 331 |
|
|
2018
Q3 | $384K | Sell |
4,875
-251
| -5% | -$17.9K | 0.04% | 399 |
|
|
2018
Q2 | $330K | Sell |
5,126
-2,026
| -28% | -$134K | 0.02% | 454 |
|
|
2018
Q1 | $445K | Sell |
7,152
-12
| -0.2% | -$861 | 0.03% | 370 |
|
|
2017
Q4 | $519K | Sell |
7,164
-10,188
| -59% | -$741K | 0.04% | 355 |
|
|
2017
Q3 | $1.41M | Buy |
17,352
+2,818
| +19% | +$223K | 0.13% | 158 |
|
|
2017
Q2 | $1.12M | Sell |
14,534
-4,688
| -24% | -$370K | 0.17% | 129 |
|
|
2017
Q1 | $1.49M | Sell |
19,222
-954
| -5% | -$76.2K | 0.15% | 139 |
|
|
2016
Q4 | $1.59M | Buy |
+20,176
| New | +$1.63M | 0.2% | 107 |
|
Other funds holding CVS
VCM
VPM
Level Four Advisory Services's CVS Position: Q1 2026 in Review
Level Four Advisory Services increased its CVS Health (CVS) stake by 25% in Q1 2026, buying an estimated $183K and bringing the position to 12,003 shares worth $862K. The position accounts for 0.03% of the portfolio, ranked #451.
Level Four Advisory Services first reported a position in CVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $9.93M in Q1 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Level Four Advisory Services held 12,003 shares of CVS Health worth $862K as of Q1 2026.
- Level Four Advisory Services bought 2,373 CVS Health shares in Q1 2026, an estimated $183K.
- CVS Health made up 0.03% of Level Four Advisory Services's portfolio in Q1 2026, its #451 holding.
- Level Four Advisory Services first reported a position in CVS Health in Q4 2016 and has held it in 38 quarters since.
- Level Four Advisory Services's CVS Health position peaked at $9.93M in Q1 2025.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Level Four Advisory Services's 13F filing for Q1 2026, filed 14 May 2026.